Helaina raises $45m series B round to support market entry of human lactoferrin
Helaina is targeting the women’s health, active nutrition and healthy aging markets, says founder and CEO Laura Katz.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
